LEAP2 and pancreatic insulinoma: The present study provides two novel findings: (i) serum LEAP2 concentrations are significantly elevated in patients with insulinoma and correlate with insulin levels, and (ii) LEAP2 peptide is extensively expressed in insulinoma tissues.